Catalyst Pharmaceutical Partners (CPRX) PT Raised to $6.50 at Roth Capital
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Roth Capital analyst Scott Henry raised the price target on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) to $6.50 (from $6.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Kweichow Moutai Co Ltd (600519:CH) PT Lowered to RMB1,400 at JPMorgan
- Sunac China Holdings Limited (1918:HK) (SCCCF) PT Lowered to HK$0.30 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
